Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

Sammy Huygens(Ghent University Hospital), Bart Rijnders(Rega Institute for Medical Research), Marion Koopmans(National Institute for Public Health and the Environment), Arvind Gharbharan(Erasmus MC), Bas B. Oude Munnink(University of Amsterdam)
Clinical Infectious Diseases
July 22, 2022
Cited by 50


Related Papers